Literature DB >> 27122767

Bipolar Disorder and Schizophrenia Present Different Risks of Atrial fibrillation: A Nationwide Population-Based Analysis.

Hung-Yu Yang1, Jen-Hung Huang2, Yung-Kuo Lin3, Chien-Yeh Hsu4, Shih-Ann Chen5, Yi-Jen Chen3.   

Abstract

BACKGROUND: Atrial fibrillation (AF) is increasingly prevalent in society, and can elevate cardiac morbidity and mortality. Psychosis and gender are known to play important roles in the genesis of AF. However, it is not clear whether gender modulates the impact of different psychoses on the occurrences of AF.
METHODS: We identified patients suffering from bipolar disorder and schizophrenia, with and without AF, using the Taiwan National Health Insurance nationwide database. The identified patient population consisted of 927,915 subjects (463,050 males and 464,865 females) from 2001 to 2008, which included 2,963 (3.2 ‰) schizophrenia patients (1,650 males and 1,313 females) and 5,112 (5.5 ‰) bipolar-disorder patients (1,934 males and 3,178 females).
RESULTS: The male and female bipolar-disorder patients had higher prevalences of AF than did male (16.5 ‰ vs. 2.4 ‰, p < 0.001) and female (12.9 ‰ vs. 2.3 ‰, p < 0.001) schizophrenia patients. Furthermore, male and female bipolar-disorder patients had higher AF prevalences than did males (8.5 ‰, p < 0.001) and females (7.2 ‰, p < 0.001) in the general population. Schizophrenia patients had lower AF prevalence than the general population in male, but not in female gender. Males had a higher AF prevalence than females. However, male and female bipolar disorder and schizophrenia patients had similar AF prevalences. Those patients with schizophrenia and bipolar-disorder patients with AF were older than those without AF.
CONCLUSIONS: Differing risk factors for AF were identified in bipolar-disorder and schizophrenia patients. Compared to the general population, gender may have different impacts on the occurrence of AF in psychosis patients. KEY WORDS: Atrial fibrillation; Bipolar disorder; Population-based study; Schizophrenia.

Entities:  

Year:  2014        PMID: 27122767      PMCID: PMC4804820     

Source DB:  PubMed          Journal:  Acta Cardiol Sin        ISSN: 1011-6842            Impact factor:   2.672


  25 in total

1.  Tension and anxiety and the prediction of the 10-year incidence of coronary heart disease, atrial fibrillation, and total mortality: the Framingham Offspring Study.

Authors:  Elaine D Eaker; Lisa M Sullivan; Margaret Kelly-Hayes; Ralph B D'Agostino; Emelia J Benjamin
Journal:  Psychosom Med       Date:  2005 Sep-Oct       Impact factor: 4.312

2.  Clozapine induced atrial fibrillation.

Authors:  R A Low; M A Fuller; A Popli
Journal:  J Clin Psychopharmacol       Date:  1998-04       Impact factor: 3.153

3.  Psychopathology and symptoms of atrial fibrillation: implications for therapy.

Authors:  Anil K Gehi; Samuel Sears; Neeta Goli; T Jennifer Walker; Eugene Chung; Jennifer Schwartz; Kathryn A Wood; Kimberly Guise; J Paul Mounsey
Journal:  J Cardiovasc Electrophysiol       Date:  2012-03-19

Review 4.  Depression, the autonomic nervous system, and coronary heart disease.

Authors:  Robert M Carney; Kenneth E Freedland; Richard C Veith
Journal:  Psychosom Med       Date:  2005 May-Jun       Impact factor: 4.312

5.  Anxiety, depression, and stress as risk factors for atrial fibrillation after cardiac surgery.

Authors:  Phillip J Tully; Jayme S Bennetts; Robert A Baker; Andrew D McGavigan; Deborah A Turnbull; Helen R Winefield
Journal:  Heart Lung       Date:  2010-05-08       Impact factor: 2.210

6.  Incidence of and risk factors for atrial fibrillation in older adults.

Authors:  B M Psaty; T A Manolio; L H Kuller; R A Kronmal; M Cushman; L P Fried; R White; C D Furberg; P M Rautaharju
Journal:  Circulation       Date:  1997-10-07       Impact factor: 29.690

Review 7.  Role of inflammation in initiation and perpetuation of atrial fibrillation: a systematic review of the published data.

Authors:  Tim T Issac; Hisham Dokainish; Nasser M Lakkis
Journal:  J Am Coll Cardiol       Date:  2007-11-05       Impact factor: 24.094

Review 8.  New concepts in atrial fibrillation: mechanism and remodeling.

Authors:  Chung-Chuan Chou; Peng-Sheng Chen
Journal:  Med Clin North Am       Date:  2008-01       Impact factor: 5.456

9.  The natural history of atrial fibrillation: incidence, risk factors, and prognosis in the Manitoba Follow-Up Study.

Authors:  A D Krahn; J Manfreda; R B Tate; F A Mathewson; T E Cuddy
Journal:  Am J Med       Date:  1995-05       Impact factor: 4.965

Review 10.  Incidence of schizophrenia and other psychoses in England, 1950-2009: a systematic review and meta-analyses.

Authors:  James B Kirkbride; Antonia Errazuriz; Tim J Croudace; Craig Morgan; Daniel Jackson; Jane Boydell; Robin M Murray; Peter B Jones
Journal:  PLoS One       Date:  2012-03-22       Impact factor: 3.240

View more
  5 in total

Review 1.  The Application and Future of Big Database Studies in Cardiology: A Single-Center Experience.

Authors:  Kuang-Tso Lee; Ai-Ling Hour; Ben-Chang Shia; Pao-Hsien Chu
Journal:  Acta Cardiol Sin       Date:  2017-11       Impact factor: 2.672

Review 2.  Cardiovascular disease in patients with severe mental illness.

Authors:  René Ernst Nielsen; Jytte Banner; Svend Eggert Jensen
Journal:  Nat Rev Cardiol       Date:  2020-10-30       Impact factor: 32.419

3.  The Connection between Cardiac and Mental Disorder: Atrial Fibrillation in Patients with Psychiatric Disorder.

Authors:  Fa-Po Chung; Yenn-Jiang Lin
Journal:  Acta Cardiol Sin       Date:  2014-01       Impact factor: 2.672

4.  Atrial Fibrillation and Injected Aripiprazole: A Case Report.

Authors:  Anthi Stefatos; Julie N Ha; Adrian Baranchuk; Ross J Baldessarini; Gustavo H Vázquez
Journal:  Innov Clin Neurosci       Date:  2018-06-01

5.  Vitamin D and bisphosphonates therapies for osteoporosis are associated with different risks of atrial fibrillation in women: A nationwide population-based analysis.

Authors:  Hung-Yu Yang; Jen-Hung Huang; Hung-Wen Chiu; Yung-Kuo Lin; Chien-Yeh Hsu; Yi-Jen Chen
Journal:  Medicine (Baltimore)       Date:  2018-10       Impact factor: 1.817

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.